While there's been no documented catch of a Burmese python by Florida's bionic-bunny project, it's still in the testing phase ...
In 2023, I wrote an article about speeding up Python calculations with functools.cache. The execution time at the time went ...
Show me the facts Explain it like I’m 5 Give me a lighthearted recap Back at university, I wrote quite a few Python programs ...
New Phase 2 REC-4881 data presented at CGA-IGC in an expanded adult population aged 18 years and older show deep, durable polyp burden ...
Recursive, an AI startup founded last year, is starting to live up to its name. The company, which is trying to build AI that can improve itself, released its first model, Flint, on Wednesday. Flint ...
For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The last time I spoke about Recursion Pharmaceuticals (RXRX), it was with a Seeking Alpha article entitled "Recursion: "Hold" Rating Based On Initial REC-4881 FAP Treatment Data." With respect to this ...
Recursion Pharmaceuticals Inc. (RXRX) announced Thursday that Sanofi (SNY) has selected the first development candidate under their research collaboration, triggering a $10 million milestone payment ...
Most patients (21 of 26; 80.8%) had TRAEs of Grade 2 or lower, consistent with MEK1/2 inhibition, including dermatitis acneiform, rash, CPK increase, diarrhea, and asymptomatic LVEF decrease. Grade 3 ...
The Linux creator calls vibe coding 'a wonderful way to find joy in programming,' but not for running Linux development. (Finding bugs is OK.) Also: Linus Torvalds is using AI to develop Linux kernel ...
Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...